Nath Bio-Genes (India) Limited (NATHBIOGEN) Financial History

Name: Nath Bio-Genes (India) Limited (NATHBIOGEN) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Basic Materials · Agricultural Inputs · DATA UPDATED 2026-09-20

Nath Bio-Genes (India) Limited (NATHBIOGEN) operates in the Agricultural Inputs industry and is headquartered in Mumbai, India with about 452 employees. Its market capitalization is roughly ₹3 billion. In the fiscal year ended 2026-03-31, NATHBIOGEN reported ₹4.5B in revenue and ₹416M in net income.

Nath Bio-Genes (India) Limited engages in the production, processing, and marketing of hybrid and GM seeds in India and internationally. It operates in two segments, Agricultural Activities and Trading Activities.

Interactive charts & full statements →

NATHBIOGEN Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹4.5B	₹3.6B	₹3.3B	₹3.0B
Gross Profit	₹2.4B	₹2.4B	₹2.2B	₹1.9B
Operating Income (EBIT)	₹491M	₹475M	₹468M	₹460M
Net Income	₹416M	₹386M	₹396M	₹350M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NATHBIOGEN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹3.3B	₹516M	₹660M	₹438M	₹2.8B
Gross Profit	₹1.6B	₹358M	₹372M	₹267M	₹1.4B
Operating Income (EBIT)	₹342M	₹34M	₹26M	₹51M	₹283M
Net Income	₹323M	(₹0M)	₹16M	₹28M	₹283M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NATHBIOGEN Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹38M)	(₹38M)	(₹38M)	(₹38M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NATHBIOGEN Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	₹11.0B	₹10.3B	₹8.8B	₹7.9B	—
Total Liabilities	₹4.2B	₹3.8B	₹2.7B	₹2.2B	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NATHBIOGEN viewer.

Other Companies in Agricultural Inputs

KHAICHEM · Khaitan Chemicals and Fertilizers Limited — ₹5 billion
RAMAPHO · Rama Phosphates Limited — ₹4 billion
IGCL · Indogulf Cropsciences Limited — ₹4 billion
SDF · K+S Aktiengesellschaft — €3 billion
SIKKO · Sikko Industries Limited — ₹3 billion
KWS · KWS SAAT SE & Co. KGaA — €3 billion
NOVAAGRI · Nova Agritech Limited — ₹2 billion
INDOUS · Indo Us Bio-Tech Limited — ₹2 billion

← NATH All “N” companies NATI →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.